- Corporate Officers - P
- Perceptive Life Sciences Master Fund Ltd
Insider Trading History of Perceptive Life Sciences Master Fund Ltd
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Perceptive Life Sciences Master Fund Ltd since 2008.
The trader's CIK number is 1249675.
At the time of the last reporting, Perceptive Life Sciences Master Fund Ltd was the 10% Owner of Athira Pharma, Inc.. (stock ticker symbol ATHA).
Also see all insider trading activities at Athira Pharma, Inc..
Note that in the past
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Zonagen Inc (RPRX) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | RPRX | 413,695 | $1,968,288 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Optimer Pharmaceuticals Inc (OPTR) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | OPTR | 0 | $0 | 200,000 | $1,480,000 | 0 | $0 |
Yearly summary of insider trading at Aegerion Pharmaceuticals, Inc. (AEGR) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | AEGR | 625,000 | $16,921,725 | 750,000 | $66,900,000 | 0 | $0 |
| 2012 | AEGR | 20,000 | $425,400 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aravive, Inc. (VSAR) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | VSAR | 334,589 | $4,828,808 | 0 | $0 | 0 | $0 |
| 2016 | VSAR | 47,375 | $680,589 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Corium International, Inc. (CORI) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | CORI | 1,902,400 | $11,890,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Amicus Therapeutics, Inc. (FOLD) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | FOLD | 94,750 | $470,054 | 0 | $0 | 0 | $0 |
| 2016 | FOLD | 416,900 | $1,958,481 | 1,100,000 | $7,491,000 | 0 | $0 |
| 2015 | FOLD | 800,000 | $5,337,750 | 0 | $0 | 0 | $0 |
| 2014 | FOLD | 6,100,000 | $27,650,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aldeyra Therapeutics, Inc. (ALDX) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | ALDX | 893,025 | $4,018,612 | 0 | $0 | 0 | $0 |
| 2016 | ALDX | 700,000 | $3,500,000 | 0 | $0 | 0 | $0 |
| 2015 | ALDX | 150,265 | $969,537 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Penwest Pharmaceuticals Co (PPCO) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | PPCO | 12,600 | $63,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Xtl Biopharmaceuticals Ltd (XTLB) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | XTLB | 0 | $0 | 40,050,370 | $6,057,205 | 0 | $0 |
Yearly summary of insider trading at Acelrx Pharmaceuticals Inc (ACRX) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | ACRX | 0 | $0 | 609,350 | $2,294,466 | 0 | $0 |
| 2015 | ACRX | 0 | $0 | 578,300 | $2,661,083 | 0 | $0 |
| 2013 | ACRX | 1,565,660 | $14,757,677 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vbi Vaccines Inc. (VBIV) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | VBIV | 3,383,955 | $10,321,062 | 0 | $0 | 0 | $0 |
| 2015 | VBIV | 650,000 | $1,352,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Athira Pharma, Inc. (ATHA) by Perceptive Life Sciences Master Fund Ltd
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ATHA | 1,058,824 | $18,000,008 | 0 | $0 | 0 | $0 |
Insider trading activities at 12 companies by Perceptive Life Sciences Master Fund Ltd:
1. Zonagen Inc (RPRX)
2. Optimer Pharmaceuticals Inc (OPTR)
3. Aegerion Pharmaceuticals, Inc. (AEGR)
4. Aravive, Inc. (VSAR)
5. Corium International, Inc. (CORI)
6. Amicus Therapeutics, Inc. (FOLD)
7. Aldeyra Therapeutics, Inc. (ALDX)
8. Penwest Pharmaceuticals Co (PPCO)
9. Xtl Biopharmaceuticals Ltd (XTLB)
10. Acelrx Pharmaceuticals Inc (ACRX)
11. Vbi Vaccines Inc. (VBIV)
12. Athira Pharma, Inc. (ATHA)
Table 1. Insider trading of Zonagen Inc (RPRX) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-03-16 | RPRX | Buy | 86,500 | 5.21 | 450,232 |
| 2011-03-07 | RPRX | Buy | 30,000 | 6.47 | 194,100 |
| 2011-03-01 | RPRX | Buy | 50,000 | 4.62 | 231,000 |
| 2011-02-28 | RPRX | Buy | 88,273 | 4.46 | 393,697 |
| 2011-02-24 | RPRX | Buy | 110,000 | 4.36 | 479,600 |
| 2011-02-25 | RPRX | Buy | 48,922 | 4.49 | 219,659 |
Table 2. Insider trading of Optimer Pharmaceuticals Inc (OPTR) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-07-02 | OPTR | Sale | 200,000 | 7.40 | 1,480,000 |
Table 3. Insider trading of Aegerion Pharmaceuticals, Inc. (AEGR) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-09-05 | AEGR | Sale | 750,000 | 89.20 | 66,900,000 |
| 2013-02-01 | AEGR | Buy | 50,000 | 27.79 | 1,389,400 |
| 2013-01-18 | AEGR | Buy | 50,000 | 27.62 | 1,381,000 |
| 2013-01-17 | AEGR | Buy | 50,000 | 26.73 | 1,336,300 |
| 2013-01-11 | AEGR | Buy | 475,000 | 26.98 | 12,815,025 |
| 2012-12-04 | AEGR | Buy | 20,000 | 21.27 | 425,400 |
Table 4. Insider trading of Aravive, Inc. (VSAR) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-02-13 | VSAR | Buy | 59,133 | 15.52 | 917,448 |
| 2017-02-10 | VSAR | Buy | 34,883 | 14.94 | 521,291 |
| 2017-02-08 | VSAR | Buy | 104,612 | 13.51 | 1,413,308 |
| 2017-02-09 | VSAR | Buy | 41,211 | 14.27 | 587,916 |
| 2016-12-30 | VSAR | Buy | 94,750 | 14.66 | 1,388,845 |
| 2016-12-29 | VSAR | Buy | 47,375 | 14.37 | 680,589 |
Table 5. Insider trading of Corium International, Inc. (CORI) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-05-25 | CORI | Buy | 1,902,400 | 6.25 | 11,890,000 |
Table 6. Insider trading of Amicus Therapeutics, Inc. (FOLD) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-12-30 | FOLD | Buy | 94,750 | 4.96 | 470,054 |
| 2016-12-28 | FOLD | Buy | 47,375 | 4.91 | 232,706 |
| 2016-12-29 | FOLD | Buy | 94,750 | 4.85 | 459,916 |
| 2016-12-23 | FOLD | Buy | 85,275 | 4.82 | 411,025 |
| 2016-12-22 | FOLD | Buy | 189,500 | 4.51 | 854,834 |
| 2016-08-25 | FOLD | Sale | 1,100,000 | 6.81 | 7,491,000 |
| 2015-10-07 | FOLD | Buy | 50,000 | 6.27 | 313,500 |
| 2015-10-05 | FOLD | Buy | 500,000 | 6.80 | 3,402,500 |
| 2015-10-06 | FOLD | Buy | 250,000 | 6.49 | 1,621,750 |
| 2014-11-19 | FOLD | Buy | 2,100,000 | 6.50 | 13,650,000 |
| 2014-06-30 | FOLD | Buy | 4,000,000 | 3.50 | 14,000,000 |
Table 7. Insider trading of Aldeyra Therapeutics, Inc. (ALDX) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-02-14 | ALDX | Buy | 893,025 | 4.50 | 4,018,612 |
| 2016-05-26 | ALDX | Buy | 700,000 | 5.00 | 3,500,000 |
| 2015-10-28 | ALDX | Buy | 45,100 | 6.50 | 293,150 |
| 2015-10-26 | ALDX | Buy | 50,000 | 6.46 | 323,150 |
| 2015-10-22 | ALDX | Buy | 18,020 | 6.47 | 116,661 |
| 2015-10-20 | ALDX | Buy | 37,145 | 6.37 | 236,576 |
Table 8. Insider trading of Penwest Pharmaceuticals Co (PPCO) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-10-24 | PPCO | Buy | 3,000 | 5.00 | 15,000 |
| 2008-10-15 | PPCO | Buy | 300 | 5.00 | 1,500 |
| 2008-09-29 | PPCO | Buy | 4,500 | 5.00 | 22,500 |
| 2008-10-15 | PPCO | Buy | 300 | 5.00 | 1,500 |
| 2008-09-29 | PPCO | Buy | 4,500 | 5.00 | 22,500 |
Table 9. Insider trading of Xtl Biopharmaceuticals Ltd (XTLB) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-11-19 | XTLB | Sale | 9,600,000 | .15 | 1,459,200 |
| 2008-11-18 | XTLB | Sale | 30,450,370 | .15 | 4,598,005 |
Table 10. Insider trading of Acelrx Pharmaceuticals Inc (ACRX) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-09-29 | ACRX | Sale | 97,200 | 3.88 | 377,136 |
| 2016-09-28 | ACRX | Sale | 119,300 | 3.96 | 472,428 |
| 2016-09-15 | ACRX | Sale | 392,850 | 3.68 | 1,444,902 |
| 2015-11-17 | ACRX | Sale | 133,900 | 5.36 | 717,436 |
| 2015-11-18 | ACRX | Sale | 42,300 | 5.35 | 226,135 |
| 2015-11-06 | ACRX | Sale | 17,100 | 4.47 | 76,368 |
| 2015-11-05 | ACRX | Sale | 75,000 | 4.62 | 346,275 |
| 2015-09-09 | ACRX | Sale | 310,000 | 4.18 | 1,294,869 |
| 2013-11-07 | ACRX | Buy | 100,000 | 6.50 | 649,800 |
| 2013-11-06 | ACRX | Buy | 100,000 | 6.52 | 651,700 |
| 2013-11-04 | ACRX | Buy | 155,000 | 6.86 | 1,063,145 |
| 2013-10-31 | ACRX | Buy | 200,000 | 6.69 | 1,338,600 |
| 2013-11-01 | ACRX | Buy | 160,660 | 7.17 | 1,151,932 |
| 2013-07-23 | ACRX | Buy | 850,000 | 11.65 | 9,902,500 |
Table 11. Insider trading of Vbi Vaccines Inc. (VBIV) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-12-06 | VBIV | Buy | 3,383,955 | 3.05 | 10,321,062 |
| 2015-08-14 | VBIV | Buy | 650,000 | 2.08 | 1,352,000 |
Table 12. Insider trading of Athira Pharma, Inc. (ATHA) by Perceptive Life Sciences Master Fund Ltd
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-09-22 | ATHA | Buy | 1,058,824 | 17.00 | 18,000,008 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Perceptive Life Sciences Master Fund Ltd
(10% Owner of Athira Pharma, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.